| Neuroactive ligand–receptor interaction |
340/8040 |
2.58E-11 |
6.64E-09 |
0.00000001 |
| Vascular smooth muscle contraction |
132/8040 |
4.90E-08 |
6.30E-06 |
0.00000537 |
| cAMP signaling pathway |
216/8040 |
2.44E-07 |
2.09E-05 |
0.00001779 |
| Calcium signaling pathway |
193/8040 |
4.46E-07 |
2.86E-05 |
0.00002440 |
| Dilated cardiomyopathy (DCM) |
96/8040 |
1.62E-06 |
8.33E-05 |
0.00007096 |
| Arrhythmogenic right ventricular cardiomyopathy (ARVC) |
77/8040 |
3.33E-06 |
0.00014 |
0.00011966 |
| Hypertrophic cardiomyopathy (HCM) |
90/8040 |
3.83E-06 |
0.00014 |
0.00011966 |
| Pancreatic secretion |
102/8040 |
1.70E-05 |
0.000546 |
0.00046522 |
| Cell adhesion molecules (CAMs) |
148/8040 |
2.40E-05 |
0.000685 |
0.00058390 |
| Insulin secretion |
86/8040 |
5.79E-05 |
0.001487 |
0.00126717 |
| cGMP-PKG signaling pathway |
167/8040 |
0.000112 |
0.002621 |
0.00223331 |
| Protein digestion and absorption |
95/8040 |
0.000155 |
0.00331 |
0.00281991 |
| Renin secretion |
69/8040 |
0.000811 |
0.014904 |
0.01269720 |
| Fat digestion and absorption |
43/8040 |
0.000812 |
0.014904 |
0.01269720 |
| Focal adhesion |
201/8040 |
0.000996 |
0.016124 |
0.01373677 |
| Adrenergic signaling in cardiomyocytes |
149/8040 |
0.001004 |
0.016124 |
0.01373677 |
| Drug metabolism - cytochrome P450 |
72/8040 |
0.001108 |
0.016744 |
0.01426520 |
| Aldosterone-regulated sodium reabsorption |
37/8040 |
0.001959 |
0.027971 |
0.02382945 |
| Cortisol synthesis and secretion |
65/8040 |
0.002295 |
0.031038 |
0.02644201 |
| Aldosterone synthesis and secretion |
98/8040 |
0.002842 |
0.036521 |
0.03111326 |
| Chemical carcinogenesis |
83/8040 |
0.003022 |
0.036981 |
0.03150577 |
| ECM–receptor interaction |
88/8040 |
0.004487 |
0.052421 |
0.04465959 |
| Bile secretion |
90/8040 |
0.005209 |
0.058203 |
0.04958528 |
